Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.

MLA

Bassand, Jean-Pierre, et al. “Oral Anticoagulation across Diabetic Subtypes in Patients with Newly Diagnosed Atrial Fibrillation: A Report from the GARFIELD-AF Registry.” Diabetes, Obesity & Metabolism, vol. 25, no. 10, Oct. 2023, pp. 3040–53. EBSCOhost, https://doi.org/10.1111/dom.15202.

APA

Bassand, J.-P., Virdone, S., Camm, A. J., Fox, K. A. A., Goldhaber, S. Z., Goto, S., Haas, S., Hacke, W., Kayani, G., Keltai, M., Misselwitz, F., Pieper, K. S., Turpie, A. G. G., Verheugt, F. W. A., & Kakkar, A. K. (2023). Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry. Diabetes, Obesity & Metabolism, 25(10), 3040–3053. https://doi.org/10.1111/dom.15202

Chicago

Bassand, Jean-Pierre, Saverio Virdone, A John Camm, Keith A A Fox, Samuel Z Goldhaber, Shinya Goto, Sylvia Haas, et al. 2023. “Oral Anticoagulation across Diabetic Subtypes in Patients with Newly Diagnosed Atrial Fibrillation: A Report from the GARFIELD-AF Registry.” Diabetes, Obesity & Metabolism 25 (10): 3040–53. doi:10.1111/dom.15202.